OCT Angiography for Alzheimer's Disease

OCT Angiography and NRAI in Dementia

Recruiting Observational Study
Alzheimer Disease Dementia Mild Cognitive Impairment
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
55 and older
Sex
Any
Study type
Observational
Participants needed
20 (estimated)
Sponsor
Oregon Health and Science University · Other
Who this trial is looking for

This trial is looking for people aged over 55 with mild dementia or Alzheimer's disease. Participants will have tests to check their eye health and blood flow in the retina.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with probable Alzheimer's disease.
  • I have mild dementia with a score of 20 or greater on the Mini-Mental State Exam.
  • I am older than 55 years.
  • I can follow the study procedures.
  • I can see well enough, at least 20/400 in either eye.
  • I have someone who can help me with consent and attend visits.

You may not be able to join if

  • I have another neurological disease like multiple sclerosis or Parkinson's.
  • I have had other eye problems that could affect the study.
  • I have had eye surgery other than cataract removal.
  • I cannot keep my eyes steady for the imaging.
  • I can't provide informed consent.
  • I have uncontrolled high blood pressure.
  • I am pregnant or breastfeeding.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The primary goals of this study are to use optical coherence tomography (OCT) angiography (blood vessel mapping) to: 1. Detect retinal blood vessel and blood flow changes in participants with dementia. 2. Detect amyloid protein deposits in the retinas of participants with dementia.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria for dementia subjects: * Physician-confirmed diagnosis of probable Alzheimer's disease * Mild dementia, as defined by score of 20 or greater on the Mini-Mental State Exam, or score of 15 or greater on the Montreal Cognitive Assessment, or Clinical Dementia Rating Scale score of 1…
Contacts

Denzil Romfh, OD

503-494-4351

romfhd@ohsu.edu

CONTACT

Humberto Martinez, COT

503-494-7712

martinhu@ohsu.edu

CONTACT